InfuSystem (NYSE:INFU) Upgraded at StockNews.com

StockNews.com upgraded shares of InfuSystem (NYSE:INFU) from a buy rating to a strong-buy rating in a report published on Monday.

Separately, Lake Street Capital upgraded shares of InfuSystem to a strong-buy rating in a report on Thursday, May 9th.

InfuSystem Stock Down 0.3 %

INFU opened at $6.47 on Monday. InfuSystem has a fifty-two week low of $5.74 and a fifty-two week high of $10.99.

InfuSystem (NYSE:INFU) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $33.70 million for the quarter.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Rhumbline Advisers boosted its holdings in shares of InfuSystem by 13.8% in the second quarter. Rhumbline Advisers now owns 17,658 shares of the company’s stock valued at $121,000 after buying an additional 2,145 shares during the period. ARS Investment Partners LLC boosted its holdings in shares of InfuSystem by 11.4% in the second quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock valued at $229,000 after buying an additional 3,422 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of InfuSystem by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock valued at $641,000 after buying an additional 5,391 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in shares of InfuSystem by 52.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock valued at $178,000 after buying an additional 8,917 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in shares of InfuSystem by 1.7% in the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock valued at $9,288,000 after buying an additional 18,432 shares during the period.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.